University of Minnesota School of Medicine

Minneapolis, Minnesota 55454

Use our guide to learn which trials are right for you!

We've found
1 trials
at this facility
Acute Myeloid Leukemia Clinical Trial
A Trial of the FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients With FLT3/Internal Tandem Duplication (ITD) Acute Myeloid Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Minnesota School of Medicine
mi
from
Minneapolis, MN
Click here to add this to my saved trials